3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
18
Prostatic Neoplasms
14
Lung Neoplasms
13
Colorectal Neoplasms
13
Lymphoma
5
Hematologic Neoplasms
5
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Hematopoietic and Lymphatic System Neoplasm
4
Anatomic Stage I Breast Cancer AJCC v8
4
Triple Negative Breast Neoplasms
3
Papillomavirus Infections
3
Pancreatic Neoplasms
3
Obesity-Related Malignant Neoplasm
3
Melanoma
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Skin Carcinoma
2
Neoplasms
2
Multiple Myeloma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphoid System Neoplasm
2
Healthy Subject
2
Genital Neoplasms, Female
2
Endometrial Neoplasms
2
Breast Carcinoma In Situ
2
Advanced Malignant Solid Neoplasm
2
Vulvar Neoplasms
1
Interventions
Specimen Handling
7
Biopsy
6
Cyclophosphamide
5
ruxolitinib
4
Mycophenolic Acid
4
Busulfan
4
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Tacrolimus
3
Melphalan
3
Injections
3
Decitabine
3
Cyclosporine
3
Azacitidine
3
venetoclax
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
veliparib
1
tocilizumab
1
tagraxofusp
1
posaconazole
1
peginterferon alfa-2b
1
onvansertib
1
merphos
1
iadademstat
1
gilteritinib
1
fedratinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
Early Intervention, Educational
×
1 year
×
Clear all
No trials found.